Infant cataracts no better with IOLs than contact lenses

Article

Online research in the Archives of Opthalmology has reported that contact lenses for infants who had undergone surgery for unilateral congenital cataracts resulted in similar visual outcomes for those who received an IOL implant.

Online research in the Archives of Opthalmology has reported that contact lenses for infants who had undergone surgery for unilateral congenital cataracts resulted in similar visual outcomes for those who received an IOL implant.

A total of 114 infants, aged between 1-6 months had cataract surgery and received either primary IOL implantation or contact lenses to correct aphakia. Visual acuity was then tested when the infants reached one year of age and no significant difference was found between the groups.

The authors, led by Dr Scott Lambert of Emory University in Atlanta wrote: “The theoretical long-term benefit of having the IOL in the capsular bag versus implanted in the ciliary sulcus as a secondary procedure cannot be quantified at this point. We suggest that practitioners continue to exercise caution when considering implanting IOLs in infants. The ultimate role for IOL implantation during infancy may be further clarified after a longer follow-up of these children.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.